21 July 2021
The MHRA has published its Annual Report and Accounts for 2020 to 2021.
The report provides an overview of the Agency’s activities over the past year, including its work in relation to the pandemic, Brexit and the Independent Medicines and Medical Devices Safety Review.
In relation to activity on device regulation, MHRA Chief Executive, Dr June Rain, commented:
New opportunities in how we regulate medicines and medical devices are opening up with the end of the year-long transition period after leaving the EU. Our initial approach to preparing for our new role as a sovereign regulator has been pragmatic, including introduction of reliance on EU decisions and the implementation of grace periods for medical device requirements. We continue to work with the EU as the responsible regulatory authority for Northern Ireland and we have supported industry in relation to the provisions of the Northern Ireland Protocol.